Global Ketorolac Injection Market Research Report 2021

1 Ketorolac Injection Market Overview

• 1.1 Product Overview and Scope of Ketorolac Injection
• 1.2 Ketorolac Injection Segment by Type
  • 1.2.1 Global Ketorolac Injection Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 15mg/ml
  • 1.2.3 30mg/ml
• 1.3 Ketorolac Injection Segment by Application
  • 1.3.1 Ketorolac Injection Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital
  • 1.3.3 Clinics
  • 1.3.4 Recovery Center
• 1.4 Global Ketorolac Injection Market Size Estimates and Forecasts
  • 1.4.1 Global Ketorolac Injection Revenue 2016-2027
  • 1.4.2 Global Ketorolac Injection Sales 2016-2027
  • 1.4.3 Ketorolac Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Ketorolac Injection Market Competition by Manufacturers

• 2.1 Global Ketorolac Injection Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Ketorolac Injection Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Ketorolac Injection Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Ketorolac Injection Manufacturing Sites, Area Served, Product Type
• 2.5 Ketorolac Injection Market Competitive Situation and Trends
  • 2.5.1 Ketorolac Injection Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Ketorolac Injection Players Market Share by Revenue
  • 2.5.3 Global Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Ketorolac Injection Retrospective Market Scenario by Region

• 3.1 Global Ketorolac Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Ketorolac Injection Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Ketorolac Injection Market Facts & Figures by Country
  • 3.3.1 North America Ketorolac Injection Sales by Country
  • 3.3.2 North America Ketorolac Injection Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Ketorolac Injection Market Facts & Figures by Country
  • 3.4.1 Europe Ketorolac Injection Sales by Country
  • 3.4.2 Europe Ketorolac Injection Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Ketorolac Injection Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Ketorolac Injection Sales by Region
  • 3.5.2 Asia Pacific Ketorolac Injection Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Ketorolac Injection Market Facts & Figures by Country
  • 3.6.1 Latin America Ketorolac Injection Sales by Country
  • 3.6.2 Latin America Ketorolac Injection Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Ketorolac Injection Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Ketorolac Injection Sales by Country
  • 3.7.2 Middle East and Africa Ketorolac Injection Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Ketorolac Injection Historic Market Analysis by Type

• 4.1 Global Ketorolac Injection Sales Market Share by Type (2016-2021)
• 4.2 Global Ketorolac Injection Revenue Market Share by Type (2016-2021)
• 4.3 Global Ketorolac Injection Price by Type (2016-2021)

5 Global Ketorolac Injection Historic Market Analysis by Application

• 5.1 Global Ketorolac Injection Sales Market Share by Application (2016-2021)
• 5.2 Global Ketorolac Injection Revenue Market Share by Application (2016-2021)
• 5.3 Global Ketorolac Injection Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Almaject
  • 6.1.1 Almaject Corporation Information
  • 6.1.2 Almaject Description and Business Overview
  • 6.1.3 Almaject Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Almaject Product Portfolio
  • 6.1.5 Almaject Recent Developments/Updates
• 6.2 Amphastar
  • 6.2.1 Amphastar Corporation Information
  • 6.2.2 Amphastar Description and Business Overview
  • 6.2.3 Amphastar Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Amphastar Product Portfolio
  • 6.2.5 Amphastar Recent Developments/Updates
• 6.3 Fresenius Kabi
  • 6.3.1 Fresenius Kabi Corporation Information
  • 6.3.2 Fresenius Kabi Description and Business Overview
  • 6.3.3 Fresenius Kabi Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Fresenius Kabi Product Portfolio
  • 6.3.5 Fresenius Kabi Recent Developments/Updates
• 6.4 Hikma
  • 6.4.1 Hikma Corporation Information
  • 6.4.2 Hikma Description and Business Overview
  • 6.4.3 Hikma Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Hikma Product Portfolio
  • 6.4.5 Hikma Recent Developments/Updates
• 6.5 Pfizer
  • 6.5.1 Pfizer Corporation Information
  • 6.5.2 Pfizer Description and Business Overview
  • 6.5.3 Pfizer Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Pfizer Product Portfolio
  • 6.5.5 Pfizer Recent Developments/Updates
• 6.6 Sagent
  • 6.6.1 Sagent Corporation Information
  • 6.6.2 Sagent Description and Business Overview
  • 6.6.3 Sagent Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Sagent Product Portfolio
  • 6.6.5 Sagent Recent Developments/Updates
• 6.7 Alvogen
  • 6.6.1 Alvogen Corporation Information
  • 6.6.2 Alvogen Description and Business Overview
  • 6.6.3 Alvogen Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Alvogen Product Portfolio
  • 6.7.5 Alvogen Recent Developments/Updates
• 6.8 Athenex
  • 6.8.1 Athenex Corporation Information
  • 6.8.2 Athenex Description and Business Overview
  • 6.8.3 Athenex Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Athenex Product Portfolio
  • 6.8.5 Athenex Recent Developments/Updates
• 6.9 BD RX
  • 6.9.1 BD RX Corporation Information
  • 6.9.2 BD RX Description and Business Overview
  • 6.9.3 BD RX Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 BD RX Product Portfolio
  • 6.9.5 BD RX Recent Developments/Updates
• 6.10 Fosun Pharma
  • 6.10.1 Fosun Pharma Corporation Information
  • 6.10.2 Fosun Pharma Description and Business Overview
  • 6.10.3 Fosun Pharma Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Fosun Pharma Product Portfolio
  • 6.10.5 Fosun Pharma Recent Developments/Updates
• 6.11 Virtus Pharmaceuticals
  • 6.11.1 Virtus Pharmaceuticals Corporation Information
  • 6.11.2 Virtus Pharmaceuticals Ketorolac Injection Description and Business Overview
  • 6.11.3 Virtus Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Virtus Pharmaceuticals Product Portfolio
  • 6.11.5 Virtus Pharmaceuticals Recent Developments/Updates

7 Ketorolac Injection Manufacturing Cost Analysis

• 7.1 Ketorolac Injection Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Ketorolac Injection
• 7.4 Ketorolac Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Ketorolac Injection Distributors List
• 8.3 Ketorolac Injection Customers

9 Ketorolac Injection Market Dynamics

• 9.1 Ketorolac Injection Industry Trends
• 9.2 Ketorolac Injection Growth Drivers
• 9.3 Ketorolac Injection Market Challenges
• 9.4 Ketorolac Injection Market Restraints

10 Global Market Forecast

• 10.1 Ketorolac Injection Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Ketorolac Injection by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Ketorolac Injection by Type (2022-2027)
• 10.2 Ketorolac Injection Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Ketorolac Injection by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Ketorolac Injection by Application (2022-2027)
• 10.3 Ketorolac Injection Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Ketorolac Injection by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Ketorolac Injection by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List